Human YTHDC1/YT521/YT521-B ORF/cDNA clone-Lentivirus plasmid (NM_001031732.4)

Cat. No.: pGMLV001639
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human YTHDC1/YT521/YT521-B Lentiviral expression plasmid for YTHDC1 lentivirus packaging, YTHDC1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to YTHDC1/YT521 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1042.56
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLV001639
Gene Name YTHDC1
Accession Number NM_001031732.4
Gene ID 91746
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2184 bp
Gene Alias YT521,YT521-B
Fluorescent Reporter Null
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCGGCTGACAGTCGGGAGGAGAAAGATGGAGAACTTAATGTTCTGGATGATATTTTAACTGAAGTACCAGAACAAGATGATGAACTGTATAATCCAGAGAGTGAACAAGATAAAAATGAGAAAAAGGGATCAAAAAGAAAAAGTGATCGAATGGAATCTACTGATACCAAACGACAAAAGCCTTCTGTCCATTCTAGACAACTGGTTTCTAAGCCACTGAGCTCATCTGTTAGCAATAACAAAAGAATAGTTAGTACAAAAGGAAAGTCAGCCACAGAGTATAAAAATGAGGAATATCAAAGATCTGAAAGAAACAAGCGTCTAGATGCTGATCGGAAAATTCGTCTATCAAGTAGTGCCTCCAGAGAACCTTATAAGAATCAACCTGAAAAAACCTGTGTCCGGAAAAGGGATCCTGAAAGGAGGGCCAAATCTCCTACGCCAGATGGTTCTGAGAGAATTGGGCTTGAAGTGGATAGACGTGCAAGCAGATCCAGCCAGTCTTCTAAGGAAGAAGTGAACTCTGAAGAATATGGCTCTGACCATGAGACTGGCAGCAGTGGTTCTTCTGATGAGCAAGGGAACAACACTGAGAATGAGGAGGAAGGAGTGGAAGAAGATGTGGAGGAAGATGAAGAAGTAGAAGAAGATGCAGAAGAAGATGAAGAGGTGGATGAAGATGGAGAGGAGGAGGAGGAAGAGGAGGAGGAGGAAGAGGAGGAGGAGGAGGAGGAAGAAGAAGAATATGAACAGGATGAGAGAGACCAGAAAGAGGAGGGAAATGATTATGACACTCGAAGTGAGGCCAGTGACTCTGGTTCTGAATCTGTTTCCTTCACAGATGGGTCTGTCAGATCTGGTTCAGGCACAGATGGATCAGATGAGAAAAAGAAGGAAAGGAAGAGAGCTAGAGGCATATCTCCAATTGTTTTTGATAGAAGTGGAAGCTCTGCATCAGAGTCATATGCAGGTTCAGAAAAGAAGCATGAGAAATTATCATCTTCCGTTCGTGCTGTCCGAAAAGATCAAACCAGTAAACTCAAATATGTGCTTCAAGATGCAAGATTTTTCCTCATAAAGAGTAACAACCATGAGAATGTGTCTCTTGCCAAAGCGAAGGGTGTATGGTCCACGCTCCCTGTAAATGAGAAGAAATTAAATCTTGCATTTAGATCTGCAAGGAGTGTTATCTTAATATTTTCTGTCAGAGAGAGTGGAAAATTTCAAGGGTTTGCAAGACTTTCTTCAGAATCACATCACGGAGGATCTCCTATACACTGGGTGCTTCCAGCAGGAATGAGTGCTAAAATGCTGGGAGGTGTCTTTAAAATTGACTGGATTTGCAGGCGTGAATTACCCTTCACTAAGTCGGCTCATCTCACCAATCCTTGGAATGAACATAAACCAGTAAAGATCGGACGTGATGGACAGGAAATTGAACTTGAATGTGGAACCCAGCTTTGTCTTCTGTTTCCCCCCGATGAAAGTATTGACTTGTATCAGGTCATTCATAAAATGCGTCACAAGAGAAGAATGCATTCTCAGCCCCGATCACGAGGACGTCCATCCCGTCGAGAACCAGTCCGGGATGTGGGAAGGCGTCGACCAGAAGATTATGATATTCATAACAGCAGAAAGAAACCAAGGATTGACTATCCCCCTGAGTTTCACCAGAGACCAGGGTATTTAAAGGATCCACGATACCAGGAAGTGGACAGACGATTTTCAGGAGTTCGCCGAGATGTGTTTTTAAATGGGTCCTACAATGATTATGTGAGGGAATTTCATAACATGGGACCACCACCACCTTGGCAAGGAATGCCCCCTTACCCAGGAATGGAACAACCTCCACACCATCCTTACTATCAGCACCATGCTCCACCTCCTCAAGCTCATCCCCCTTACTCAGGACATCATCCAGTACCACATGAAGCAAGATACAGAGATAAACGAGTACATGATTATGATATGAGGGTGGATGATTTCCTTCGTCGCACACAAGCTGTTGTCAGTGGCCGGAGAAGTAGACCCCGTGAAAGAGACCGGGAACGAGAGCGAGACCGCCCTAGAGATAACAGACGAGACAGAGAGCGAGATAGAGGACGTGATAGAGAAAGAGAAAGAGAGCGATTATGTGATCGAGACAGAGACCGAGGGGAGAGAGGTCGATATAGAAGATAA
ORF Protein Sequence MAADSREEKDGELNVLDDILTEVPEQDDELYNPESEQDKNEKKGSKRKSDRMESTDTKRQKPSVHSRQLVSKPLSSSVSNNKRIVSTKGKSATEYKNEEYQRSERNKRLDADRKIRLSSSASREPYKNQPEKTCVRKRDPERRAKSPTPDGSERIGLEVDRRASRSSQSSKEEVNSEEYGSDHETGSSGSSDEQGNNTENEEEGVEEDVEEDEEVEEDAEEDEEVDEDGEEEEEEEEEEEEEEEEEEEEYEQDERDQKEEGNDYDTRSEASDSGSESVSFTDGSVRSGSGTDGSDEKKKERKRARGISPIVFDRSGSSASESYAGSEKKHEKLSSSVRAVRKDQTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRHKRRMHSQPRSRGRPSRREPVRDVGRRRPEDYDIHNSRKKPRIDYPPEFHQRPGYLKDPRYQEVDRRFSGVRRDVFLNGSYNDYVREFHNMGPPPPWQGMPPYPGMEQPPHHPYYQHHAPPPQAHPPYSGHHPVPHEARYRDKRVHDYDMRVDDFLRRTQAVVSGRRSRPRERDRERERDRPRDNRRDRERDRGRDRERERERLCDRDRDRGERGRYRR

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP2390-Ab Anti-YTDC1/ YTHDC1/ YT521 monoclonal antibody
    Target Antigen GM-Tg-g-MP2390-Ag YTHDC1 VLP (virus-like particle)
    ORF Viral Vector pGMLV001639 Human YTHDC1 Lentivirus plasmid
    ORF Viral Vector pGMLV001881 Human YTHDC1 Lentivirus plasmid
    ORF Viral Vector pGMPC001287 Human YTHDC1 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMLV001639 Human YTHDC1 Lentivirus particle
    ORF Viral Vector vGMLV001881 Human YTHDC1 Lentivirus particle


    Target information

    Target ID GM-MP2390
    Target Name YTHDC1
    Gene Group Identifier
    （Target Gene ID in Homo species)         		91746
    Gene ID 100066303 (Equus caballus), 101087921 (Felis catus), 170956 (Rattus norvegicus), 231386 (Mus musculus)
    475161 (Canis lupus familiaris), 613858 (Bos taurus), 709717 (Macaca mulatta), 91746 (Homo sapiens)
    Gene Symbols & Synonyms YTHDC1,Ythdc1,Yt521,mKIAA1966,A730098D12Rik,YT521,YT521-B
    Target Alternative Names A730098D12Rik,Splicing factor YT521 (YT521-B),YT521,YT521-B,YTH domain-containing protein 1,YTHDC1,Yt521,Ythdc1,mKIAA1966
    Uniprot Accession E9Q5K9,Q96MU7,Q9QY02
    Additional SwissProt Accessions: Q9QY02,E9Q5K9,Q96MU7
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000018303, ENSMUSG00000035851, ENSCAFG00845009010, ENSBTAG00000015572, ENSMMUG00000002265, ENSG00000083896
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.